SYMBIS will be submitted to FDA soon - according to recent quarterly transcript it will be submitted by end of year. That was close to a month ago, could happen at any time. That announcement should restore some faith in the company as it continues to move forward with growth plans. Should catch the eye of additional investors....ie those who saw MAKO get purchased or is familiar with ISRG and the $18B market cap it carries.